Premier Diagnostic Health Services Inc.
CNSX : PDH

Premier Diagnostic Health Services Inc.

March 21, 2011 19:12 ET

Premier Diagnostics Closes Private Placement

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 21, 2011) -

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA

Premier Diagnostics Health Services Inc. (CNSX:PDH) ("the Company") announced today that it has closed its previously announced non-brokered private placement. An aggregate of $147,000 was raised and 918,750 Units @ $0.16 per Unit were issued.

Each Unit consisted of one share, and one purchase warrant exercisable at $0.30 and expiring on July 31, 2011 ("A Warrant") and one purchase warrant exercisable at $0.40 and expiring on December 31, 2011 (" B Warrant"). 

The funds from this offering will be used to achieve the Company's objectives of developing additional diagnostic facilities in strategic locations across Canada and China and will also be used for general working capital purposes.

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Actual results may differ materially. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Premier.

About Premier Diagnostic Health Services Inc. ("PDH")

The company is engaged in developing and operating diagnostic imaging clinics in Canada and China, with a focus on PET-CT Scanning ("Positron Emission Tomography – Computed Tomography"). Premier is committed to providing the latest technology to enhance health options and owns and operates the first and only private PET-CT clinic in Western Canada as well as an MRI clinic in collaboration with Beijing AP Hospital No. 3 in China. The Centre for Advanced Diagnostics in Burnaby offers access to the most advanced medical imaging technology available in cancer care today, and is dedicated to meeting today's healthcare needs through delivering exceptional patient care. 

The Canadian National Stock Exchange has neither approved nor disapproved the contents of this press release.

Contact Information